Gain expertise in muscle biopsy interpretation and applications in diagnosing neuromuscular disorders!

Get ready for the EURO-NMD Neuromuscular Neuropathology Webinar Series—an exciting nine-episode journey through the world…

Read more

Basic techniques for muscle biopsies

  …TIMESLOT: Thursday 07 November 2024 16:00 CET …THEME: Basic techniques for muscle biopsies …PRESENTERS: Prof. Tiziana…

Read more

Call for Nominations: ERDERA Multistakeholder Advisory Group

The European Rare Diseases Research Alliance (ERDERA) seeks experts to join its Multistakeholder Advisory Board…

Read more

The management of amyotrophic lateral sclerosis

In March 2024, the EAN published a new guideline on the management of amyotrophic lateral…

Read more

Save the date: EURO-NMD Annual Meeting 2025 5th-7th March in Essen, Germany

EURO-NMD Annual Meeting 2025 The time has come to start preparing the 2025 edition of…

Read more

Registry Onboarding has started

Registry Onboarding has started The ERN EURO-NMD Registry Hub intends to collect data from the…

Read more

ERN EURO-NMD: "Breaking barriers and building bridges in rare Neuromuscular Diseases"

What is an European Reference Network?

To review a patient’s diagnosis and treatment, ERN coordinators convene ‘virtual’ advisory boards of medical specialists across different disciplines, using a dedicated IT platform and telemedicine tools.

ERNs offer the potential to give patients and doctors across the EU access to the best expertise and timely exchange of life-saving knowledge,...

Read more

About EURO-NMD

EURO-NMD is a European Reference Network for the thematic grouping of rare neuromuscular diseases (NMDs), a broad group of related disorders that represent a major cause of mortality and lifelong disability in children and adults. NMDs are caused by acquired or genetic defects of motorneurons, peripheral nerves, neuromuscular junctions or...

Read more

Relevant EURO-NMD resources at a distance of a click

Several essential resources support the EURO-NMD network, some supplied by the European Commission and others developed in-house. The objective is to fulfil the ERN’s goals of providing streamlined diagnostic and therapeutic features to support patient care across Europe and propel research in neuromuscular disorders.

Read more